Diligence memo · auto-generated · as of July 2, 2026

Octagon Search Equity, LLC

Octagon Search Equity, LLC looks fair against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 17.4× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Octagon Search Equity, LLC operates in Other, based in Miami.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Octagon Search Equity, LLC has raised $18M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $17M on 2026-02-20.

Most recent recorded round closed around 2026-02-20.

Valuation (modeled)modeled

Provath models Octagon Search Equity, LLC at approximately $70M (range $42M–$91M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.82× the median modeled value of Series B Other companies in 2025–2027 (207 peers) — value vs value, same stage and era. Within the normal band (82% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 4 mo ago; this sector typically re-raises about every 11 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 17.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 84% of Other peers (25015 compared).

Modeled value ranks above 77% of those peers.

Closest niche peers: Acorn Sim Investor Holdings, LLC, Aircapture, Inc., Bathhouse Holdings Inc., Chlorum Solutions USA LLC, Olympus Pines LLC.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.